Vimarsana
Biggest News Aggregation in the World

Page 33 - Steven Deeks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven Deeks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Deeks Today - Breaking & Trending Today

HIV and COVID-19: What Do We Know Now? - Vimarsana News

HIV and COVID-19: What Do We Know Now?

HIV and COVID-19: What Do We Know Now? Advertisement HIV and COVID-19: What Do We Know Now? Larger studies suggest people living with HIV might have a modestly higher risk of severe COVID-19, but much remains to be learned. Advertisement In the early days of the pandemic, POZ published a roundup of What People With HIV Need to Know About the New Coronavirus. Many HIV-positive people were concerned about their risk because immune suppression is linked to more severe COVID-19. What’s more, nearly half of people living with HIV are over 50 and many have underlying health condition...

Source: poz.com
FDA Approves 1st Long-Acting HIV Drug Combo, Monthly Shots - Vimarsana News

FDA Approves 1st Long-Acting HIV Drug Combo, Monthly Shots

U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace daily pills.

FDA approves 1st long-acting HIV drug combo, monthly shots | Taiwan News - Vimarsana News

FDA approves 1st long-acting HIV drug combo, monthly shots | Taiwan News

FDA approves 1st long-acting HIV drug combo, monthly shots | 2021/01/22

FDA approves first long-acting HIV drug combo - Vimarsana News

FDA approves first long-acting HIV drug combo

U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus.

FDA approves monthly HIV treatment from ViiV Healthcare, which has major RTP presence, - Vimarsana News

FDA approves monthly HIV treatment from ViiV Healthcare, which has major RTP presence,

RESEARCH TRIANGLE PARK - U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to